Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Down 3.8% – Time to Sell?

Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF) were down 3.8% on Tuesday . The stock traded as low as $0.9801 and last traded at $1.00. Approximately 416,524 shares were traded during mid-day trading, an increase of 521% from the average daily volume of 67,097 shares. The stock had previously closed at $1.04.

Cardiol Therapeutics Stock Down 3.8%

The firm’s fifty day moving average price is $1.02 and its 200-day moving average price is $1.11.

Cardiol Therapeutics Company Profile

Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.

Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.